A detailed history of Asset Management One Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 664,864 shares of GILD stock, worth $60.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
664,864
Previous 652,847 1.84%
Holding current value
$60.8 Million
Previous $44.8 Million 24.42%
% of portfolio
0.2%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$66.59 - $83.99 $800,212 - $1.01 Million
12,017 Added 1.84%
664,864 $55.7 Million
Q2 2024

Jul 18, 2024

SELL
$63.15 - $72.88 $1.18 Million - $1.36 Million
-18,644 Reduced 2.78%
652,847 $44.8 Million
Q1 2024

May 02, 2024

SELL
$71.58 - $87.29 $1.73 Million - $2.11 Million
-24,143 Reduced 3.47%
671,491 $49.2 Million
Q4 2023

Jan 24, 2024

SELL
$73.27 - $83.09 $965,771 - $1.1 Million
-13,181 Reduced 1.86%
695,634 $56.4 Million
Q3 2023

Oct 19, 2023

SELL
$73.94 - $80.67 $321,639 - $350,914
-4,350 Reduced 0.61%
708,815 $53.1 Million
Q2 2023

Jul 31, 2023

SELL
$76.01 - $86.7 $5.3 Million - $6.04 Million
-69,692 Reduced 8.9%
713,165 $55 Million
Q1 2023

Apr 25, 2023

BUY
$77.31 - $88.08 $2.1 Million - $2.4 Million
27,227 Added 3.6%
782,857 $65 Million
Q4 2022

Feb 06, 2023

SELL
$62.32 - $89.47 $2.73 Million - $3.92 Million
-43,867 Reduced 5.49%
755,630 $64.9 Million
Q3 2022

Nov 04, 2022

SELL
$59.54 - $68.01 $1.61 Million - $1.84 Million
-27,094 Reduced 3.28%
799,497 $49.3 Million
Q2 2022

Jul 29, 2022

SELL
$57.72 - $65.01 $352,092 - $396,561
-6,100 Reduced 0.73%
826,591 $51.1 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $3.77 Million - $4.73 Million
-65,137 Reduced 7.25%
832,691 $49.5 Million
Q4 2021

Feb 09, 2022

BUY
$64.88 - $73.64 $42,885 - $48,676
661 Added 0.07%
897,828 $66.1 Million
Q3 2021

Nov 02, 2021

SELL
$67.69 - $73.03 $1.48 Million - $1.6 Million
-21,897 Reduced 2.38%
897,167 $62.7 Million
Q2 2021

Aug 03, 2021

SELL
$63.47 - $69.35 $3.45 Million - $3.76 Million
-54,284 Reduced 5.58%
919,064 $63.3 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $1.17 Million - $1.33 Million
-19,489 Reduced 1.96%
973,348 $62.9 Million
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $1.75 Million - $2 Million
30,959 Added 3.22%
992,837 $56.5 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $360,490 - $453,254
5,805 Added 0.61%
961,878 $60.8 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $16.7 Million - $19.4 Million
230,653 Added 31.8%
956,073 $73.6 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $60,124 - $77,011
-960 Reduced 0.13%
725,420 $54.2 Million
Q4 2019

Feb 14, 2020

SELL
$61.62 - $67.78 $5.18 Million - $5.7 Million
-84,048 Reduced 10.37%
726,380 $47.2 Million
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $312,612 - $345,069
-5,001 Reduced 0.61%
810,428 $51.4 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $9.89 Million - $11.1 Million
159,903 Added 24.39%
815,429 $55.1 Million
Q1 2019

May 15, 2019

SELL
$62.53 - $70.05 $92.9 Million - $104 Million
-1,486,256 Reduced 69.39%
655,526 $42.6 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $1.7 Million - $2.22 Million
28,103 Added 1.33%
2,141,782 $134 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $2.13 Million - $2.35 Million
-29,814 Reduced 1.39%
2,113,679 $163 Million
Q2 2018

Aug 14, 2018

BUY
$64.88 - $75.68 $2.15 Million - $2.5 Million
33,079 Added 1.57%
2,143,493 $152 Million
Q1 2018

May 14, 2018

BUY
$72.84 - $88.8 $1.4 Million - $1.71 Million
19,251 Added 0.92%
2,110,414 $159 Million
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $414,591 - $486,671
-5,827 Reduced 0.28%
2,091,163 $150 Million
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $2.95 Million - $3.5 Million
40,899 Added 1.99%
2,096,990 $170 Million
Q2 2017

Aug 14, 2017

BUY
N/A
2,056,091
2,056,091 $146 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.